Related Experiment Videos
[Sildenafil improves right ventricular function in a cardiac transplant recipient]
Rodrigo Pereira Paez1, Wesley Ferreira Araujo, Nelson Americo Hossne
1Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP. rppaez@yahoo.com.br
Arquivos Brasileiros De Cardiologia
|March 12, 2005
Summary
Sildenafil effectively treated cardiogenic shock in a cardiac transplant patient with severe pulmonary hypertension. The medication improved right ventricular function and reduced the need for vasoactive drugs, aiding hemodynamic recovery.
Area of Science:
- Cardiology
- Pharmacology
- Transplantation Medicine
Background:
- Orthotopic cardiac transplantation is a life-saving procedure for end-stage heart failure.
- Marginal donors are often necessary for critically ill recipients, posing unique management challenges.
- Pulmonary hypertension and vasoplegia can lead to severe right ventricular dysfunction post-transplant.
Observation:
- A male patient undergoing orthotopic cardiac transplantation experienced critical cardiogenic shock.
- The patient developed right ventricular dysfunction secondary to pulmonary hypertension and vasoplegia.
- Conventional vasoactive drugs were insufficient to manage the patient's hemodynamic instability.
Findings:
- Introduction of sildenafil led to significant hemodynamic recovery.
- Sildenafil administration resulted in decreased pulmonary vascular resistance.
- The patient's right ventricular function improved, allowing for withdrawal of vasoactive drugs.
Implications:
- Sildenafil represents a potential therapeutic option for managing refractory pulmonary hypertension and right ventricular dysfunction post-cardiac transplantation.
- This case highlights the utility of targeted pharmacotherapy in optimizing outcomes for high-risk transplant recipients.
- Further research into sildenafil's role in post-transplant pulmonary vascular complications is warranted.